Landshut, Germany

Wolfgang Christian Hans

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Actogenix N.v., Vlaams Interuniversitair Instituut Voor Biotechnologie. Active years: 2007-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Christian Hans. Retrieved from https://idiyas.com/inventor/wolfgang-christian-hans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wolfgang Christian Hans: Innovator in Gastro-Intestinal Treatments

Introduction

Wolfgang Christian Hans is a notable inventor based in Landshut, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for gastro-intestinal disorders. With a total of 2 patents, his work focuses on innovative methods for delivering therapeutic peptides.

Latest Patents

His latest patents revolve around the delivery of trefoil peptides. The inventions relate to a microorganism, specifically a non-pathogenic bacterial strain, that delivers a trefoil peptide in vivo. The preferred trefoil peptide is TFF1. The inventions also include methods for delivering the trefoil peptide to the gastro-intestinal tract through the administration of such bacterial strains. Furthermore, these patents encompass pharmaceutical compositions that utilize trefoil peptide delivering bacteria, as well as methods for treating acute gastro-intestinal inflammatory diseases. This includes the treatment of acute colitis and flare-ups of Crohn's disease and ulcerative colitis in humans, along with similar gastro-intestinal disorders in other animal species.

Career Highlights

Throughout his career, Wolfgang has worked with prominent organizations such as the Vlaams Interuniversitair Instituut Voor Biotechnologie and Actogenix N.V. His experience in these institutions has contributed to his expertise in biotechnology and the development of innovative treatments.

Collaborations

Wolfgang has collaborated with notable individuals in his field, including Lothar Steidler and Erik René Remaut. These collaborations have further enhanced his research and development efforts.

Conclusion

Wolfgang Christian Hans is a distinguished inventor whose work in delivering trefoil peptides has the potential to revolutionize treatments for gastro-intestinal disorders. His innovative approach and dedication to biotechnology continue to make a significant impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…